BLUMENTHAL, DURBIN, HIRONO, & MERKLEY DEMAND ANSWERS AFTER UNQUALIFIED ORGANIZATION WITH CLOSE TIES TO ICE RECEIVES NO-BID CONTRACT TO PROVIDE LEGAL SERVICES TO MIGRANT CHILDREN
“This award is concerning given the incredible lack of details provided in the award notice, the nonexistence of legal services provided by your organization, the Trump Administration’s continued use of no-bid awards…and the Trump Administration’s staggering disregard for the welfare of children in immigration enforcement.” [WASHINGTON, D.C.] – U.S. Senator
Wyden, Merkley Demand Federal Agencies Stop Sharing Medicaid Data With ICE
Washington, D.C. – U.S. Senators Ron Wyden and Jeff Merkley today demanded that the federal departments of Health and Human Services (HHS) and Homeland Security (DHS) as well as the Centers for Medicare & Medicaid Services (CMS) immediately stop unlawfully transferring Medicaid data to DHS and the U.S. Immigration and Customs Enforcement (ICE). “Congress has a responsibility to
Merkley, Wyden Secure Federal Funding to Expand Pollinator Habitat Along Oregon Highways
Washington, D.C. — Today, Oregon’s U.S. Senators Jeff Merkley and Ron Wyden announced $150,000 in federal funds for the Oregon Department of Transportation (ODOT) to create and restore pollinator habitats along Oregon highways.The funding, which is the maximum award under the Federal Highway Administration’s Pollinator-Friendly Practices on Roadsides and Highway Rights-of-Way Program
Merkley, Wyden Announce Over $6.5 Million in Transit Grants for Oregon
Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden today announced that the Lane Transit and Rogue Valley Transportation Districts will receive $3,952,851, and $2,687,000, respectively, in federal grants to support critical bus and bus facility upgrades. The Rogue Valley Transportation District’s grant will help replace, rehabilitate, and purchase
Merkley, Wyden Announce Over $7 Million to Help First-Generation, Low-Income Students, and Students with Disabilities Succeed in College
Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden today announced that over $7 million in TRIO grants are headed to 19 higher education institutions across Oregon to support first-generation, low-income students, and students with disabilities through the Student Support Services Program. Students who receive the grant will have
Merkley Continues Push for Expanded Work Share Provisions in Next Relief Package
WASHINGTON – Oregon’s U.S. Senator Jeff Merkley is pushing Senate leadership today to include ideas from his legislation, the Rebuilding Main Street Act, within the next relief package. The Rebuilding Main Street Act would incentivize and expand the use of the Work Share program, which allows businesses and nonprofits to
Wyden, Merkley Join Colleagues to Introduce Comprehensive Legislation to Help Achieve Environmental Justice for All
Washington, D.C. – Oregon’s U.S. Sens. Ron Wyden and Jeff Merkley recently joined U.S. Sens. Kamala D. Harris, D-Calif., Cory Booker, D-N.J., and Tammy Duckworth, D-Ill., to introduce the Environmental Justice for All Act to improve health equity and climate justice for all, particularly underserved communities and communities of color. As the nation reckons with systemic racism, the
Merkley, Wyden Introduce Resolution Celebrating the 55th Anniversary of the Voting Rights Act of 1965
WASHINGTON – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden today introduced a Senate Resolution to recognize, commemorate, and celebrate the 55th anniversary of the enactment of the landmark Voting Rights Act of 1965. President Lyndon Johnson proposed the legislation just days after the civil rights march from Selma to
Merkley, Smith Unveil Plan to Prevent Pharmaceutical Companies from Price Gouging COVID-19 Vaccines, Treatments
WASHINGTON, D.C. – Oregon’s U.S. Senator Jeff Merkley continued his leadership in tackling pharmaceutical companies’ price gouging by teaming up with U.S. Senator Tina Smith (D-MN) today to introduce legislation to ensure that any taxpayer-funded vaccine or treatment for coronavirus (COVID-19) proven to be safe and effective will be accessible,